|
시장보고서
상품코드
2058595
체외진단용 실험실 자동화 시장 : 제품 유형별, 용도별, 프로세스별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Lab Automation for In-Vitro Diagnostics Market, By Product Type, By Application, By Process Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
체외진단용 실험실 자동화 시장 규모는 2025년에 60억 520만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 7.3%로 확대될 것으로 전망됩니다.
체외진단용 실험실 자동화란, 자동화 장비, 로봇 시스템, 소프트웨어 플랫폼 및 디지털 워크플로를 활용하여 수작업을 최소화하고 임상 검사를 수행하는 것을 의미합니다. 이러한 시스템은 시료 전처리, 검사, 데이터 기록, 결과 분석과 같은 업무를 보다 체계적이고 효율적으로 관리하는 데 도움이 됩니다. 자동화는 검사 결과의 일관성을 높이고, 업무 지연을 줄이며, 대규모 임상 검사를 지원하기 위해 병원, 진단 센터 및 연구소에서 널리 활용되고 있습니다. 또한, 다양한 의료 현장에서 의료진이 질환의 조기 발견, 환자 모니터링, 치료 계획 수립에 필요한 진단 정보를 보다 신속하게 제공할 수 있도록 지원합니다.
전 세계 의료 시스템이 검사실 인프라와 디지털 의료 서비스를 지속적으로 강화해 나가는 가운데, 체외진단용 검사실 자동화 시장은 꾸준히 성장하고 있습니다. 미국 식품의약국(FDA)은 안전하고 신뢰할 수 있는 자동 검사 환경을 지원하기 위해 체외 진단, 실험실용 소프트웨어의 검증 및 커넥티드 헬스케어 시스템에 관한 규제 지침을 지속적으로 확대하고 있습니다. 세계보건기구(WHO)는 진단 서비스가 의료적 의사결정의 약 70%에 영향을 미친다고 밝히며, 각국에 검사 업무의 현대화와 양질의 진단 서비스에 대한 접근성 개선을 장려하고 있습니다. 아시아태평양 및 중동 각국 정부 역시 스마트 병원, 분자 검사 시설, 검사실 디지털화 프로그램에 대한 투자를 확대하고 있으며, 이는 전 세계적으로 자동 분석기, 로봇 기반 검체 처리 시스템, 통합형 검사 워크플로 기술의 보급을 촉진하고 있습니다.
체외진단용 실험실 자동화 시장 - 시장 역학
시장 확대를 뒷받침하는, 더욱 신속하고 대량적인 진단 검사에 대한 수요 증가
의료 시스템이 방대한 양의 환자 검체와 복잡한 검사 절차를 관리하는 가운데, 보다 신속하고 대량 처리가 가능한 진단 검사에 대한 수요 증가는 체외진단용 검사실 자동화 시장의 주요 촉진요인이 되고 있습니다. 검사실에서는 수작업의 부담을 줄이고 검사 효율을 높이기 위해 자동 분석기, 로봇 검체 처리 시스템, 디지털 워크플로 플랫폼의 도입이 점점 더 확대되고 있습니다. 세계보건기구(WHO)는 진단 결과가 의료적 의사결정의 약 70%에 영향을 미친다고 밝히며, 신뢰할 수 있고 시의적절한 검사 서비스의 중요성이 커지고 있음을 강조하고 있습니다.
아시아 및 기타 의료 발전도상국에서는 각국이 검사 인프라를 강화하고, 분자 검사 및 감염병 검사 프로그램에 대한 접근성을 확대하고 있습니다. 로슈나 애보트 같은 기업들은 보다 신속한 임상 검사와 대규모 검체 관리를 지원하기 위해 자동화 진단 플랫폼 및 통합 검사 시스템의 도입을 추진하고 있습니다. 정확하고 확장성이 뛰어나며, 지속적인 검사 업무에 대한 수요가 증가함에 따라 병원과 진단 센터는 자동화된 체외 진단 기술을 활용하여 검사실의 현대화를 추진하고 있습니다.
체외진단용 실험실 자동화 시장 - 시장 세분화 분석:
전 세계 체외진단용 실험실 자동화 시장은 제품 유형, 용도, 공정 유형, 최종사용자 및 지역별로 세분화되어 있습니다.
제품 유형별로 보면 시장은 5가지 유형으로 분류됩니다. 신속하고 정확하며 대량의 임상 검사에 대한 수요가 증가함에 따라, 자동 분석 장비가 체외 진단용 실험실 자동화 시장에서 중요한 역할을 하고 있습니다. 의료 검사실은 검사의 일관성을 유지하면서 수작업을 줄이는 동시에 더 많은 환자 검체를 처리해야 한다는 지속적인 압박에 시달리고 있습니다. 자동 분석 장치는 통합된 검체 처리, 처리 속도 향상 및 디지털 데이터 관리를 통해 검사실 업무 흐름의 효율성 제고에 기여합니다. 로슈(Roche)와 같은 기업들은 분자진단, 면역분석 및 임상화학 검사를 지원하기 위해 연결된 분석 장비 시스템과 지능형 실험실 자동화 플랫폼을 강화하고 있습니다. 업계 보고서에 따르면, 검사실이 복잡한 진단 업무를 관리하고 검사 환경에서의 인적 오류를 줄이기 위해 업무 현대화를 추진하는 가운데, 자동 액체 처리 기술 및 분석 장비 기술의 도입이 확대되고 있는 것으로 나타났습니다. 표준화된 진단 워크플로우에 대한 수요 증가, 검사량 증가, 그리고 디지털 의료 인프라의 보급으로 인해, 병원 및 진단 센터들은 일상적인 검사 및 전문적인 검사 용도를 위해 첨단 자동 분석 장비 시스템에 대한 투자를 확대하고 있습니다.
체외진단용 실험실 자동화 시장 - 지역별 분석
지역별 전망을 살펴보면, 아시아태평양에서는 검사실 인프라의 현대화와 첨단 진단 서비스에 대한 접근성 확대가 진행되고 있어, 체외진단용 실험실 자동화 시장이 상당한 성장을 기록할 것으로 예상됩니다. 각국 정부는 검사 효율성과 환자 치료의 질을 높이기 위해 디지털 헬스케어 프로그램, 지능형 병원 시스템, 그리고 검사실 표준화 이니셔티브를 지원하고 있습니다. 중국은 자동화 임상 검사실, 감염병 감시 및 정밀 의학 프로그램에 대한 투자가 증가함에 따라, 이러한 추세에서 중요한 국가로 부상하고 있습니다. 해당국은 의료 현대화 정책과 디지털 병원 네트워크 확장을 통해 스마트 헬스케어 기술 도입을 추진하고 있습니다. Mindray, 시스멕스, Fapon 등의 기업들은 병원 및 진단 센터 전반에 걸쳐 증가하는 검사 수요에 대응하기 위해 자동 분석기, 로봇식 검체 처리 시스템, 지능형 검사실 플랫폼의 강화에 주력하고 있습니다. 세계보건기구(WHO)에 따르면, 의료적 의사결정의 약 70%가 진단 검사의 영향을 받는 반면, 많은 국가에서는 여전히 신뢰할 수 있는 검사 시스템과 필수 진단 검사에 대한 접근성 확대가 추진되고 있습니다. 이와 동시에 미국 식품의약국(FDA)은 체외진단 의료기기, 실험실 개발 검사, 소프트웨어 검증 및 전자 검사 데이터 통합에 관한 규제 지침을 지속적으로 강화하고 있으며, 전 세계 제조업체들에게 자동화의 품질과 워크플로우의 신뢰성을 높일 것을 촉구하고 있습니다. 이러한 추세는 아시아태평양의 의료 제공자, 연구 기관 및 검사실 운영자들이 보다 신속하고 표준화된 진단 검사 서비스를 구현할 수 있도록, 확장성이 뛰어나고 디지털로 연결된 검사실 자동화 기술의 도입을 촉진하고 있습니다.
한국의 체외진단용 실험실 자동화 시장 - 국가별 분석
한국은 디지털 헬스케어 인프라, AI를 활용한 진단, 그리고 스마트 병원 프로그램에 대한 지속적인 투자를 통해 체외진단용 실험실 자동화 분야에서의 입지를 공고히 하고 있습니다. 보건복지부와 과학기술정보통신부는 'AX-Sprint' 캠페인을 통해 AI 기술 주도의 헬스케어 기술 상용화를 위한 노력을 지원하고 있습니다. AX-Sprint 프로그램은 임상 검증 및 병원 시스템 통합 프로젝트에 자금을 지원하고 있습니다. 한국 정부는 최근 2032년까지 첨단 의료기기 연구개발에 약 9,400억 원을 투자할 계획이라고 밝혔습니다. 또한, 해당 국가에서는 시젠(Seegene), 시스멕스(Sysmex Corporation), 삼성의료원(Samsung Medical Center) 등의 기업들이 자동화된 분자진단 및 검사 데이터 통합 기술의 확대에 적극적으로 참여하고 있습니다. 한국에서는 의료 기관 전반의 업무 흐름 자동화와 진단 정확도 향상을 도모하기 위해 안전한 의료 데이터 공유 플랫폼과 AI 전문 병원 네트워크를 구축하고 있습니다. 'Doctor Answer 2.0'과 같은 정부 주도의 프로젝트에서는 병원과 ICT 기업의 협력을 통해 여러 질환에 대응하는 AI 의료 소프트웨어 개발을 지원하고 있습니다. 이러한 움직임에 힘입어, 전국적으로 네트워크로 연결된 자동화 진단 검사실의 도입이 촉진되고 있습니다.
목차
제1장 체외진단용 실험실 자동화 시장 개요
제2장 주요 요약
제3장 체외진단용 실험실 자동화 주요 시장 동향
제4장 체외진단용 실험실 자동화 산업 분석
제5장 체외진단용 실험실 자동화 시장 : 높아지는 지정학적 긴장의 영향
제6장 체외진단용 실험실 자동화 시장 구도
제7장 체외진단용 실험실 자동화 시장 : 제품 유형별
제8장 체외진단용 실험실 자동화 시장 : 용도별
제9장 체외진단용 실험실 자동화 시장 : 프로세스 유형별
제10장 체외진단용 실험실 자동화 시장 : 최종사용자별
제11장 체외진단용 실험실 자동화 시장 : 지역별
제12장 주요 벤더 분석 : 체외진단용 실험실 자동화 산업
제13장 AnalystView의 전방위 전망
KSM 26.06.19Lab Automation for In-Vitro Diagnostics Market size was valued at US$ 6,005.2 Million in 2025, expanding at a CAGR of 7.3% from 2026 to 2033.
Lab Automation for In-Vitro Diagnostics refers to the use of automated instruments, robotic systems, software platforms, and digital workflows to perform laboratory diagnostic testing with limited manual handling. These systems help laboratories manage activities such as sample preparation, testing, data recording, and result analysis in a more organized and efficient manner. Automation is widely used in hospitals, diagnostic centers, and research laboratories to improve testing consistency, reduce operational delays, and support large-scale clinical testing. It also assists healthcare professionals in delivering faster diagnostic information for disease detection, patient monitoring, and treatment planning across different healthcare settings.
The Lab Automation for In-Vitro Diagnostics market is developing steadily as healthcare systems worldwide continue strengthening laboratory infrastructure and digital healthcare services. The U.S. Food and Drug Administration continues expanding regulatory guidance for in-vitro diagnostics, laboratory software validation, and connected healthcare systems to support safe and reliable automated testing environments. The World Health Organization states that diagnostic services influence nearly 70% of healthcare decisions, encouraging countries to modernize laboratory operations and improve access to quality diagnostics. Governments across Asia-Pacific and the Middle East are also increasing investment in smart hospitals, molecular testing facilities, and laboratory digitalization programs, supporting broader adoption of automated analyzers, robotic sample handling systems, and integrated laboratory workflow technologies worldwide.
Lab Automation for In-Vitro Diagnostics Market- Market Dynamics
Rising demand for faster and high-volume diagnostic testing supporting market expansion
The Increasing demand for faster and high-volume diagnostic testing has become a key factor in the Lab Automation for In-Vitro Diagnostics market, as healthcare systems manage large volumes of patient samples and complex laboratory procedures. Laboratories are increasingly adopting automated analyzers, robotic sample handling systems, and digital workflow platforms to reduce manual workload and improve testing efficiency. The World Health Organization states that diagnostic results influence nearly 70% of healthcare decisions, highlighting the growing importance of reliable and timely laboratory services.
Countries across Asia and other developing healthcare regions are strengthening laboratory infrastructure and expanding access to molecular and infectious disease testing programs. Companies such as Roche and Abbott are expanding automated diagnostic platforms and integrated laboratory systems to support faster clinical testing and large-scale sample management. Increasing demand for accurate, scalable, and continuous testing operations is encouraging hospitals and diagnostic centers to modernize laboratories with automated in-vitro diagnostic technologies.
Lab Automation for In-Vitro Diagnostics Market- Segmentation Analysis:
The Global Lab Automation for In-Vitro Diagnostics Market is segmented on the basis of Product Type, Application, Process Type, End User, and Region.
Under product type categories, the market varies into five types. Automated analyzers designate its participation in the Lab Automation for In-Vitro Diagnostics market due to the increasing demand for rapid, accurate, and high-volume clinical testing. Healthcare laboratories are under continuous pressure to process larger numbers of patient samples while maintaining testing consistency and reducing manual intervention. Automated analyzers help laboratories improve workflow efficiency through integrated sample handling, faster processing, and digital data management. Companies such as Roche are strengthening connected analyzer systems and intelligent laboratory automation platforms to support molecular diagnostics, immunoassays, and clinical chemistry testing. Industry reports also indicate growing adoption of automated liquid handling and analyzer technologies as laboratories modernize operations to manage complex diagnostic workloads and reduce human error in testing environments. Increasing demand for standardized diagnostic workflows, rising laboratory testing volumes, and broader adoption of digital healthcare infrastructure are encouraging hospitals and diagnostic centers to invest in advanced automated analyzer systems for routine and specialized testing applications.
Lab Automation for In-Vitro Diagnostics Market- Geographical Insights
From a global regional outlook, Asia-Pacific is forecasted to register meaningful growth in the Lab Automation for In-Vitro Diagnostics market as healthcare systems across the region continue modernizing laboratory infrastructure and expanding access to advanced diagnostic services. Governments are supporting digital healthcare programs, intelligent hospital systems, and laboratory standardization initiatives to improve testing efficiency and patient care. China is emerging as an important country within this development due to rising investment in automated clinical laboratories, infectious disease surveillance, and precision medicine programs. The country is encouraging adoption of smart healthcare technologies through healthcare modernization policies and expansion of digital hospital networks. Companies such as Mindray, Sysmex Corporation, and Fapon are strengthening automated analyzers, robotic sample handling systems, and intelligent laboratory platforms to support growing testing requirements across hospitals and diagnostic centers. The World Health Organization states that nearly 70% of healthcare decisions are influenced by diagnostic testing, while many countries are still expanding access to reliable laboratory systems and essential diagnostics. In parallel, the U.S. Food and Drug Administration continues strengthening regulatory guidance for in-vitro diagnostics, laboratory-developed tests, software validation, and electronic laboratory data integration, encouraging global manufacturers to improve automation quality and workflow reliability. These developments are encouraging healthcare providers, research institutions, and laboratory operators across the Asia-Pacific to adopt scalable and digitally connected laboratory automation technologies for faster and more standardized diagnostic testing services
South Korea Lab Automation for In-Vitro Diagnostics Market- Country Insights
South Korea is strengthening its position in laboratory automation for in-vitro diagnostics through continued investment in digital healthcare infrastructure, AI-supported diagnostics, and smart hospital programs. The ministries of Health and Welfare and Science and ICT have been backing the commercialization efforts on AI technology-driven healthcare technologies via AX-Sprint campaign. The AX-Sprint program provides funding support to clinical validation and hospital system-integration projects. The Korean government recently revealed that it plans to spend around 940 billion won on the research and development of advanced medical devices until 2032. The country is also witnessing active participation from companies such as Seegene, Sysmex Corporation, and Samsung Medical Center in expanding automated molecular diagnostics and laboratory data integration technologies. South Korea is building secure medical data-sharing platforms and AI-specialized hospital networks to improve workflow automation and diagnostic accuracy across healthcare institutions. Government-backed projects such as Doctor Answer 2.0 are supporting development of AI medical software for multiple diseases through collaborations involving hospitals and ICT firms. These developments are encouraging broader adoption of connected and automated diagnostic laboratories throughout the country.
Lab Automation for In-Vitro Diagnostics Market- Competitive Landscape:
In response to the rising need for faster diagnostic turnaround, digital laboratory supervision, and high-throughput testing, companies operating in the Lab Automation for In-Vitro Diagnostics market are firming their technological abilities through automation upgrades, software integration, and strategic associations. Roche, Abbott, Siemens Healthineers, Danaher Corporation, and Labcorp are some of the key players who have implemented automated analyzers, AI-based laboratory testing systems, and integrated diagnostic devices to enhance workflow accuracy and sample handling efficiency.
In 2025, Siemens expanded its laboratory software capabilities through the acquisition of Dotmatics, while Abbott announced the acquisition of Exact Sciences to strengthen automated molecular diagnostics and oncology testing solutions. Companies are also investing in robotic sample handling, cloud-based laboratory data systems, and integrated testing platforms to support hospitals, clinical laboratories, and research institutions seeking efficient and standardized diagnostic operations.
Recent Developments:
In January 2026, Thermo Fisher Scientific announced a strategic collaboration with NVIDIA to advance AI-enabled scientific instruments and improve laboratory automation performance in diagnostics and research facilities. The collaboration strengthened AI-driven laboratory automation capabilities, supporting faster diagnostics, smarter workflows, and improved operational efficiency in research laboratories.
In October 2025, ARCHIMED Diagnostics finalized the acquisition of ARK Diagnostics to support expansion in automated immunoassay testing and therapeutic drug monitoring solutions. The acquisition expanded automated diagnostic testing capabilities, enhancing therapeutic monitoring efficiency and supporting broader adoption of advanced immunoassay technologies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche
- Abbott
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Becton Dickinson and Company
- Agilent Technologies
- Bio-Rad Laboratories
- QIAGEN
- Tecan Group
- PerkinElmer
- Hamilton Company
- Illumina
- Sysmex Corporation
- Hudson Robotics
- Aurora Biomed
- Eppendorf
- Beckman Coulter
- Shimadzu Corporation
- Revvity
- Others
GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Automated Analyzers
- Liquid Handling Systems
- Laboratory Robotics
- Sample Preparation Systems
- Data Management Software
GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Clinical Chemistry
- Immunoassay
- Microbiology
- Hematology
- Molecular Diagnostics
- Others
GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY PROCESS TYPE- MARKET ANALYSIS, 2020 - 2033
- Pre-Analytical Automation
- Analytical Automation
- Post-Analytical Automation
- Integrated Workflow Automation
- Sample Tracking & Storage
GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Biotechnology Companies
- Pharmaceutical Laboratories
- Others
GLOBAL LAB AUTOMATION FOR IN-VITRO DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Lab Automation for In-Vitro Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Lab Automation for In-Vitro Diagnostics Market Snippet by Product Type
- 2.1.2. Lab Automation for In-Vitro Diagnostics Market Snippet by Application
- 2.1.3. Lab Automation for In-Vitro Diagnostics Market Snippet by Process Type
- 2.1.4. Lab Automation for In-Vitro Diagnostics Market Snippet by End User
- 2.1.5. Lab Automation for In-Vitro Diagnostics Market Snippet by Country
- 2.1.6. Lab Automation for In-Vitro Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
3. Lab Automation for In-Vitro Diagnostics Key Market Trends
- 3.1. Lab Automation for In-Vitro Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Lab Automation for In-Vitro Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Lab Automation for In-Vitro Diagnostics Market Opportunities
- 3.4. Lab Automation for In-Vitro Diagnostics Market Future Trends
4. Lab Automation for In-Vitro Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Lab Automation for In-Vitro Diagnostics Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Lab Automation for In-Vitro Diagnostics Market Landscape
- 6.1. Lab Automation for In-Vitro Diagnostics Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Lab Automation for In-Vitro Diagnostics Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
- 7.1.2. Automated Analyzers
- 7.1.3. Liquid Handling Systems
- 7.1.4. Laboratory Robotics
- 7.1.5. Sample Preparation Systems
- 7.1.6. Data Management Software
8. Lab Automation for In-Vitro Diagnostics Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Clinical Chemistry
- 8.1.3. Immunoassay
- 8.1.4. Microbiology
- 8.1.5. Hematology
- 8.1.6. Molecular Diagnostics
- 8.1.7. Others
9. Lab Automation for In-Vitro Diagnostics Market - By Process Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Process Type, 2025 & 2033 (%)
- 9.1.2. Pre-Analytical Automation
- 9.1.3. Analytical Automation
- 9.1.4. Post-Analytical Automation
- 9.1.5. Integrated Workflow Automation
- 9.1.6. Sample Tracking & Storage
10. Lab Automation for In-Vitro Diagnostics Market - By End User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic Laboratories
- 10.1.4. Academic & Research Institutes
- 10.1.5. Biotechnology Companies
- 10.1.6. Pharmaceutical Laboratories
- 10.1.7. Others
11. Lab Automation for In-Vitro Diagnostics Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17.5. Denmark Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
- 11.3.18.1. Overview
- 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.18.5. Rest of the Europe Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16.5. Taiwan Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
- 11.4.17.1. Overview
- 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.17.5. Vietnam Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
- 11.4.18.1. Overview
- 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.18.5. Rest of APAC Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Lab Automation for In-Vitro Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14.5. Iran Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
- 11.6.15.1. Overview
- 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.15.5. Qatar Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
- 11.6.16.1. Overview
- 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.16.5. Rest of MEA Market Size and Forecast, By Process Type, 2020 - 2033 (US$ Million)
- 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Lab Automation for In-Vitro Diagnostics Industry
- 12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Roche
- 12.2.2. Abbott
- 12.2.3. Siemens Healthineers
- 12.2.4. Danaher Corporation
- 12.2.5. Thermo Fisher Scientific
- 12.2.6. Becton Dickinson and Company
- 12.2.7. Agilent Technologies
- 12.2.8. Bio-Rad Laboratories
- 12.2.9. QIAGEN
- 12.2.10. Tecan Group
- 12.2.11. PerkinElmer
- 12.2.12. Hamilton Company
- 12.2.13. Illumina
- 12.2.14. Sysmex Corporation
- 12.2.15. Hudson Robotics
- 12.2.16. Aurora Biomed
- 12.2.17. Eppendorf
- 12.2.18. Beckman Coulter
- 12.2.19. Shimadzu Corporation
- 12.2.20. Revvity
- 12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
